BOLD FY 2022 Earnings — Boundless Bio, Inc. Revenue & Financial Results | Market Cap Arena

BOLDBoundless Bio, Inc.

$26M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$46M

Net Income

-$46M

EPS (Diluted)

$-2.06

Cash Flow

Operating Cash Flow

-$40M

Free Cash Flow

-$41M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$77M

Total Liabilities

$159M

Stockholders' Equity

-$82M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$46M	-$25M	-83.7%
Net Income	-$46M	-$25M	-82.1%